Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101).
Comella P, Filippelli G, De Cataldis G, Massidda B, Frasci G, Maiorino L, Putzu C, Mancarella S, Palmeri S, Cioffi R, Roselli M, Buzzi F, Milia V, Gambardella A, Natale D, Bianco M, Ghiani M, Masullo P; Southern Italy Cooperative Oncology Group. Comella P, et al. Among authors: cioffi r. Ann Oncol. 2007 Feb;18(2):324-30. doi: 10.1093/annonc/mdl396. Epub 2006 Oct 27. Ann Oncol. 2007. PMID: 17071935 Free article. Clinical Trial.
Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer: a randomized phase II SICOG trial.
Comella P, Chiuri VE, De Cataldis G, Filippelli G, Maiorino L, Vessia G, Cioffi R, Mancarella S, Putzu C, Greco E, Palmeri L, Costanzo R, Avallone A, Franco L. Comella P, et al. Among authors: cioffi r. Lung Cancer. 2010 Apr;68(1):94-8. doi: 10.1016/j.lungcan.2009.05.008. Epub 2009 Jul 9. Lung Cancer. 2010. PMID: 19545929 Clinical Trial.
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trial.
Comella P, Frasci G, Panza N, De Cataldis G, Cioffi R, Curcio C, Nicolella D, Micillo E, Ianniello GP, Biondi E, Perchard J, Comella G. Comella P, et al. Among authors: cioffi r. Lung Cancer. 1996 Aug;15(1):103-14. doi: 10.1016/0169-5002(96)00575-2. Lung Cancer. 1996. PMID: 8865128 Clinical Trial.
Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G. Comella P, et al. Among authors: cioffi r. Br J Cancer. 1996 Dec;74(11):1805-11. doi: 10.1038/bjc.1996.634. Br J Cancer. 1996. PMID: 8956797 Free PMC article. Clinical Trial.
Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
Comella P, Frasci G, Panza N, Manzione L, Lorusso V, Di Rienzo G, Cioffi R, De Cataldis G, Maiorino L, Bilancia D, Nicolella G, Natale M, Carpagnano F, Pacilio C, De Lena M, Bianco A, Comella G. Comella P, et al. Among authors: cioffi r. J Clin Oncol. 1999 May;17(5):1526-34. doi: 10.1200/JCO.1999.17.5.1526. J Clin Oncol. 1999. PMID: 10334540 Clinical Trial.
Cisplatin, gemcitabine, and paclitaxel in locally advanced or metastatic non-small-cell lung cancer: a phase I-II study. Southern Italy Cooperative Oncology Group.
Frasci G, Panza N, Comella P, Nicolella GP, Natale M, Manzione L, Bilancia D, Cioffi R, Maiorino L, De Cataldis G, Belli M, Micillo E, Mascia V, Massidda B, Lorusso V, De Lena M, Carpagnano F, Contu A, Pusceddu G, Comella G. Frasci G, et al. Among authors: cioffi r. J Clin Oncol. 1999 Aug;17(8):2316-25. doi: 10.1200/JCO.1999.17.8.2316. J Clin Oncol. 1999. PMID: 10561293 Clinical Trial.
Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: interim analysis of a phase III trial of the Southern Italy Cooperative Oncology Group.
Comella P, Frasci G, Panza N, Manzione L, De Cataldis G, Cioffi R, Maiorino L, Micillo E, Lorusso V, Di Rienzo G, Filippelli G, Lamberti A, Natale M, Bilancia D, Nicolella G, Di Nota A, Comella G. Comella P, et al. Among authors: cioffi r. J Clin Oncol. 2000 Apr;18(7):1451-7. doi: 10.1200/JCO.2000.18.7.1451. J Clin Oncol. 2000. PMID: 10735892 Clinical Trial.
Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial.
Ianniello GP, De Cataldis G, Comella P, Scarpati MD, Maiorino A, Brancaccio L, Cioffi R, Lombardi A, Carnicelli P, Tinessa V. Ianniello GP, et al. Among authors: cioffi r. Cancer. 1996 Jul 1;78(1):63-9. doi: 10.1002/(SICI)1097-0142(19960701)78:1<63::AID-CNCR11>3.0.CO;2-5. Cancer. 1996. PMID: 8646728 Clinical Trial.
Carboplatin-oral etoposide personalized dosing in elderly non-small cell lung cancer patients. Gruppo Oncologico Cooperativo Sud-Italia.
Frasci G, Comella P, Panza N, De Cataldis G, Del Gaizo F, Pozzo C, Gravina A, Ruffolo P, Cioffi R, Marcatili P, Della Vittoria M, Monfardini S, Comella G. Frasci G, et al. Among authors: cioffi r. Eur J Cancer. 1998 Oct;34(11):1710-4. doi: 10.1016/s0959-8049(98)00207-x. Eur J Cancer. 1998. PMID: 9893657 Clinical Trial.
142 results